treatment

Lucy A. Godley, MD, PhD, is an expert in the care and treatment of patients with diseases of the bone marrow, including leukemias, lymphomas and multiple myeloma. She also cares for patients undergoing stem cell transplantation and patients with benign hematologic conditions.
 

Dr. David Araten is an assistant professor in the Division of Hematology at the NYU School of Medicine in New York City. Prior to holding this position, he worked as an assistant professor and instructor in hematology at Memorial Sloan-Kettering Cancer Center, also in New York City. His residency was in internal medicine at Columbia-Presbyterian Medical Center and received his medical degree from Harvard Medical School in Boston. Dr. Araten’s research has focused largely on PNH and he has published in a wide variety of peer reviewed journals on this topic.

Dr. Peffault de Latour is a full Professor of Hematology in the Hematology and Bone Marrow Transplant Department of the Saint-Louis Hospital, Paris Address Service Hématologie-Greffe, Hôpital Saint Louis

regis.peffaultdelatour@aphp.fr

Dr. Rafael Bejar, MD, PhD, is board-certified in internal medicine, oncology, and hematology, with a special interest in hematologic malignancies (blood cancers). He specializes in the care of patients with

Dr. Abel received his MD and MPH from Columbia University in 2000. He completed his postgraduate training in internal medicine at Massachusetts General Hospital and his hematology/oncology fellowship at Dana-Farber Cancer Institute. In 2007, he joined Dana-Farber and is a member of the Hematologic Malignancies staff, as well as the Center for Outcomes and Policy Research.